PRE-REGISTRATION AVAILABLE If you want to have this training scheduled Live and Exclusively for your company, we will arrange it for you. Pre-Register now and pay only once the training is scheduled on your preferred days. Click on the button below to pre-register

Learn More


If you want to have this training scheduled Live and Exclusively for your company, we will arrange it for you.

Pre-Register now and pay only once the training is scheduled on your preferred days.

Pharmaceutical Contract Manufacturing Organizations (CMOs) have become increasingly prevalent due to the globalization of the pharmaceutical supply chain. While utilizing CMOs offers numerous advantages, it also introduces distinct compliance risks, especially given that operations are not directly controlled. Notably, FDA Warning Letter trends highlight compliance and data integrity issues at foreign CMO sites, emphasizing the significance of these risks.

When engaging CMOs, your company bears full responsibility for product quality, safety, efficacy, and cGMP compliance. The FDA has clearly stated that firms utilizing CMOs are accountable for ensuring their compliance with cGMPs and regulatory commitments. Any issues identified at the CMO can lead to FDA 483s and Warning Letters directed at your firm. Thus, establishing a robust CMO management system becomes imperative to ensure proper quality oversight, uphold product safety, and maintain compliance.


This seminar focuses on equipping personnel responsible for CMO oversight with the necessary knowledge to effectively ensure quality oversight throughout the entire CMO engagement process. It covers essential aspects such as Selection and Qualification, CMO Audits, Quality Agreements, Oversight of CMO Operations, and Review of Key CMO Records. The seminar also addresses considerations for different manufacturing types and offers techniques for managing challenging CMO situations. Additionally, it explores strategies for maintaining robust CMO Oversight programs amidst COVID-19 restrictions.

Delivered in a practical how-to format, this course empowers participants with actionable skills applicable to CMO oversight in their respective organizations. Engaging case studies provide opportunities to practice these skill sets under the guidance of the instructor.


  • Understand the CMO business model
  • Understand the regulatory requirements for CMO quality oversight
  • Understand how to structure your organization for effective CMO oversight
  • Understand key points for selecting and qualifying CMOs
  • Know how to prepare for and conduct CMO Audits
  • Know how to develop a Quality Agreement and how to execute it
  • Understand key points for reviewing CMO records
  • Know how to resolve issues identified in CMO records
  • Know how to manage CMOs on an ongoing basis

  • Quality Assurance Departments
  • Quality Control Departments
  • Regulatory Affairs Departments
  • Research and Development Departments
  • Manufacturing Departments
  • Engineering Departments
  • Operations Departments
  • Production Departments
  • Pharmaceutical Development Professionals
  • Validation Professionals
  • Project Managers
  • Everyone tasked with oversight of CMO functions


DAY 1 (10.30 AM to 3 PM)

The CMO Business Model

What is CMO Oversight?

CMO Oversight and COVID-19 Restrictions

Regulatory Requirements for CMO Oversight

FDA Expectations and Warning Letters

Structuring Your Organization for CMO Oversight

  • Manufacturing
  • Chemistry / Laboratory
  • Quality Assurance
  • Regulatory Affairs
  • Project Management
  • Group Exercise # 1- Structuring Your Organization

CMO Selection and Qualification

  • Overall Considerations
  • Selection Criteria / Process
  • Qualification Criteria / Process
  • Evaluating CMOs vs. Selection / Qualification Criteria
  • Case Study # 2- Example of Selection Scoring Matrix

CMO Audits (Remote Auditing Perspective)

  • Overall Considerations
  • Qualification vs. Routine Audits
  • CMO Questionnaires
    • Purpose of Questionnaires
    • Questionnaire Topics / Responses
  • Audit Planning
    • Audit Purpose / Scope
    • Audit Agenda
  • Audit Execution
    • Document Review / Interviews
    • Time Management
    • Audit Findings / CAPAs
  • Group Exercise # 3- Audit Agenda

DAY 2 (10.30 AM to 3 PM)

The Quality Agreement

  • Regulatory Requirements
  • General Elements of the Quality Agreement
  • Negotiating the Quality Agreement
  • Executing the Quality Agreement
  • Case Study # 4- Quality Agreement: Key Pitfalls

Getting to Know Your CMO

  • Understanding CMO Operations
  • Operational/Communication Style
  • Case Study # 5- CMO Personality Types

Review of Key CMO Records

  • Batch Records
  • Change Controls
  • Deviation Investigations / CAPA
  • OOS Investigations

Hot Topic - Data Integrity Latest Updates

  • Applying consistent policies to all records
  • Data Integrity Controls
  • Flags for Parallel Record-Keeping
  • Life Cycle Assessments
  • Evaluation of Current Enforcement Trends

Ongoing CMO Oversight

  • Overall Considerations
  • Elements of Effective Ongoing CMO Oversight


Upon earning a degree in Zoology at North Carolina State University, Joy began working in the pharmaceutical and biotech industries in 1992 at Pharmacia & UpJohn performing Environmental Monitoring and Sterility Testing. Her work allowed her to move into a supervisory role at Abbott Laboratories where she oversaw the Quality Control Lab. In 1998 Joy moved to Wyeth Lederle and worked in Quality Assurance, performing GMP Compliance audits, batch record reviews, and holding annual GMP training for new employees. After working in Quality Assurance for a few years, Joy moved into Equipment Qualification and Cleaning Validation at Mallinckrodt.

With 19 years of experience as a consultant, and over 25 years total experience in the pharmaceutical and biotech industries, Joy has gained extensive knowledge of Quality Assurance, Technical Writing, Process and Cleaning Validation, and Equipment Qualification and Computer System Validation and Part 11 Compliance. She has written and executed Equipment Qualifications and Validation Protocols for numerous Companies such as Mallinckrodt, Wyeth Lederle, Merck, BioMerieux, Catalent, and Biotest, Novartis, Imprimis, Cody Laboratories, and Xceilence.

Her knowledge, experience, have made her a highly sought-after engineer, technical writer, and trainer in both the pharmaceutical and biotech industries. Joy specializes in Equipment Qualification, Cleaning Validation, and GMP Compliance Auditing, and technical writing, and GMP, Audit Preparation, and SOP writing training, Computer System Validation and Part Compliance.

In 2019 she opened her own company, McElroy Training and Consultancy, LLC which provides consultants for various projects as well as on and off – site training to pharmaceutical and biotech companies throughout the United States.

Joy also spends her time mentoring and speaking as an Empowerment Speaker. Her goal is to empower people all over the world to live their dreams though implementing 5 simple techniques she has learned and applied through the years.